Which insiders are selling Incyte Corporation (INCY)?

Incyte Corporation (NASDAQ:INCY) marched up 0.47% compared to a 52-week low price of $98.49. The shares were last seen trading -6.18% lower, taking the closing price at $98.95 on 11/20/2017. At recent session, the prices were hovering between $98.72 and $106.95. This company shares are 51.06% off its target price of $149.47 and the current market capitalization stands at $21.08B. The recent change has given its price a -12.22% deficit over SMA 50 and -35.39% deficit over its 52-week high. The stock witnessed -13.35% declines, -20.11% declines and -27.33% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found INCY’s volatility during a week at 3.69% and during a month it has been found around 3.66%.

Incyte Corporation (INCY) Top Holders

Institutional investors currently hold around $20.47 billion or 95.6% in INCY stock. Look at its top three institutional owners. Baker Bros. Advisors Lp owns $3.61 billion in Incyte Corporation, which represents roughly 17.13% of the company’s market cap and approximately 17.64% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 17,385,217 shares of the stock are valued at $1.83 billion. The third largest holder is Wellington Management Group Llp, which currently holds $1.58 billion worth of this stock and that ownership represents nearly 7.48% of its market capitalization.

Incyte Corporation 13F Filings

At the end of 09/30/2017 reporting period, 249 institutional holders increased their position in Incyte Corporation (NASDAQ:INCY) by some 13,216,567 shares, 240 decreased positions by 8,371,745 and 56 held positions by 172,454,289. That puts total institutional holdings at 194,042,601 shares, according to SEC filings. The stock grabbed 57 new institutional investments totaling 4,123,648 shares while 44 institutional investors sold out their entire positions totaling 1,018,403 shares.

Incyte Corporation (NASDAQ:INCY) Insider Trades

Multiple company employees have indulged in significant insider trading. Incyte Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Friedman Paul A has sold 28,507 shares of Incyte Corporation (INCY) in trading session dated Nov. 16, 2017. These shares are worth $3,000,077 and were traded at $105.24 each. The SEC filing shows that Gryska David W performed a sale of 3,915 shares. The Executive Vice President, CFO disposed these shares by way of transaction on Nov. 02, 2017. The company’s shares were given away at $105.63 per share worth to an income of some $413,541 on account of Gryska David W.

President, Hoppenot Herve, sold 70,502 common shares of Incyte Corporation (INCY) in the open market. In a transaction dated Sep. 18, 2017, the shares were put up for sale at an average price of $119.45, raking in a sum of $8,421,464. After this sale, 299,004 common shares of INCY are directly owned by the insider, with total stake valued at $29,586,446.

In the transaction dated Sep. 14, 2017, the great number of shares disposed came courtesy the EVP & General Manager US; Flannelly Barry P disposed a total of 714 shares at an average price of $124.25, amounting to approximately $88,715. The insider now directly owns 14,782 shares worth $1,462,679.

Incyte Corporation (INCY) Analyst Guide

Several analysts have released their opinion on Incyte Corporation (NASDAQ:INCY), with 12 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.53 average brokerage recommendation.

Previous articleOptimumBank Holdings, Inc. (OPHC) Recent Ownership Changes
Next articleThe Top Three Holders Of Acasti Pharma Inc. (ACST)